Skip to content

Imaging the Effects of Bihemispheric Transcranial Stimulation and Motor Training After Stroke.

Neuroplasticity Following Bihemispheric Transcranial Direct Current Stimulation and Motor Training in Chronic Stroke Patients.

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04195412
Enrollment
24
Registered
2019-12-11
Start date
2019-10-29
Completion date
2021-10-31
Last updated
2019-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke Rehabilitation, Transcranial Direct Current Stimulation, Neuroimaging, Neuronal Plasticity

Brief summary

Functional and structural magnetic resonance imaging (MRI) will be used to investigate neural correlates of bihemispheric transcranial direct current stimulation (tDCS) associated with upper limb rehabilitation in chronic stroke patients. For this purpose, patients included will be submitted to 10 sessions with active or sham bihemispheric tDCS associated with intensive and individualized rehabilitation. Neuroimage will be employed before and after the intervention to investigate neural correlates of expected changes in motor function.

Interventions

DEVICEtDCS + upper limb rehabilitation

Stimulation will be applied for 20 minutes by a DC stimulator (NeuroConn, Germany). During each stimulation section, a pair of saline-soaked sponge electrodes (surface 24 cm²) will be placed over C3 and C4, according to the International 10-20 EEG system. Stimulation intensity will be 2 mA with current ramping up and down of 10 seconds each. The stimulation will be followed by 40 minutes of upper limb rehabilitation. Experimental sessions will be repeated five times per week to complete 10 sessions.

DEVICESham tDCS + upper limb rehabilitation

Sham stimulation will be applied for 20 minutes by a DC stimulator (NeuroConn, Germany). During each sham stimulation section, a pair of saline-soaked sponge electrodes (surface 24 cm²) will be placed over C3 and C4, according to the International 10-20 EEG system. The anode will be placed to the affected hemisphere, while the cathode will be positioned over the unaffected hemisphere. Sham tDCS will be performed by ramping current flow for the first 10 seconds of stimulation, but switching the stimulator off automatically after 30 seconds. The sham stimulation will be followed by 40 minutes of upper limb rehabilitation. Experimental sessions will be repeated five times per week to complete 10 sessions.

Sponsors

Rio de Janeiro State Research Supporting Foundation (FAPERJ)
CollaboratorOTHER_GOV
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
CollaboratorOTHER_GOV
Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
D'Or Institute for Research and Education
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Chronic Stroke (\> 12 months) * Upper limb sensorimotor sequelae due to stroke affecting only one cerebral hemisphere * The structural integrity of the corpus callosum sensorimotor * Showing ability to perform some movement with the paretic upper limb: at least minimal active mobility of the wrist and two fingers of the paretic hand. * Score ≥ 18 at Folstein Mini-Mental State Examination

Exclusion criteria

* Score ≥ 4 at Ashworth Scale * MRI or tDCS contraindications (cardiac pacemakers; implanted medication pumps; cochlear, or eye implants; craniotomy, skin lesions at the site of stimulation; surgical clips in or near the brain; claustrophobia, history of seizures, permanent makeup or tattoos with metallic dyes…) * Prior neurological diseases * Hemodynamic instability * Pregnancy * Traumatic or orthopedic lesion limiting the range of upper limb motion * Severe comprehension deficits, apraxia or neglect that would interfere with performing the study tasks * Score \> 59 at the Fugl-Meyer Assessment of Motor Recovery after Stroke

Design outcomes

Primary

MeasureTime frameDescription
Treatment-related changes in functional magnetic resonance imagingpre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment)Brain functional changes from baseline to post-treatment
Treatment-related changes in white matterpre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment)Brain structural (white matter) changes from baseline to post-treatment

Secondary

MeasureTime frameDescription
Changes in Fugl-Meyer assessment of paretic upper limb motor functionpre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment); 30 days follow up (30 days after completing treatment) and 90 days follow up (90 days after completing treatment)Fugl-Meyer Upper Extremity (FM-UE) Scale of Motor Impairment scores changes from baseline to post-treatment, 30 and 90 days later (follow up).
Changes in Jebsen-Taylor Hand Function Test scorespre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment), follow-up 30 days, follow-up 90 daysFugl-Meyer Upper Extremity (FM-UE) Scale of Motor Impairment scores changes from baseline to post-treatment and in subsequent follow-up
Changes in Stroke Impact Scale scorespre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment), follow-up 30 days, follow-up 90 daysStroke Impact Scale scores changes from baseline to post-treatment and in subsequent follow-up

Countries

Brazil

Contacts

Primary ContactErika C Rodrigues, PhD
erika.rodrigues@idor.org+552138836000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026